Medicamen Organics  IPO

Medicamen Organics Limited launches IPO, 31,00,000 shares worth INR 10.54 cr to fund product registration, plant updates, production boosts, working capital, and corporate needs.

Important Details

Open Date : June 21, 2024 Close Date : June 25, 2024 Allotment Date: June 26, 2024 Listing Date: June 28, 2024

Important Details

IPO Price: INR 32-34 per share Lot Size: 4000 Shares Total Issue Size: INR 10.54 crores

Fundamental Analysis

Medicamen Organics analysis shows mixed performance: 1. Revenue increased,Equity & profitability improved. 2. EPS & RoNW rose,Total assets grew. 3. Inventory turnover decreased, indicating potential inefficiencies.

Peer Comparison

Medicamen Organics Ltd: 1. Strong profitability and RoNW compared to Brooks Labs & Zenotech Labs. 2. Lower revenue but higher EPS and solid financial ratios, showing stability.


Medicament Organics Ltd main objective: 1. Fund international product registration expenses. 2. Update & expand plant capacity. 3. Support working capital requirements.

Risks And Challenges

Medicament Organics Ltd risks: 1. Litigation involvement. 2. Pending licenses and permits. 3. Reliance on third-party suppliers. 4. Potential impacts on operations, finances & reputation.